Sign in

CIK 0000872589 · Large accelerated filer

REGENERON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
REGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
133444607
Phone
9148477000
Business address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Former names
REGENERON PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$51,901,544
in 11 filings, $8.6M under 10b5-1 plans

Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-10-02 McCourt Marion EVP Commercial Option exercise 10b5-1 +1,038 $372.46 $387K 20,841
2023-10-02 McCourt Marion EVP Commercial Sale 10b5-1 −1,038 $827.00 $858K 19,803
2023-10-02 McCourt Marion EVP Commercial Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −1,038 3,412
2023-09-08 Schenkein David P Director Grant or award +240 240
2023-09-08 Schenkein David P Director Grant or award · Non-Qualified Stock Option (right to buy) +2,739 2,739
2023-09-08 Guarini Kathryn Director Grant or award +240 240
2023-09-08 Guarini Kathryn Director Grant or award · Non-Qualified Stock Option (right to buy) +2,739 2,739
2023-09-01 McCourt Marion EVP Commercial Sale 10b5-1 −250 $834.55 $209K 19,803
2023-08-23 Fenimore Christopher R. SVP Controller Option exercise +7,000 $399.66 $2.8M 26,140
2023-08-23 Fenimore Christopher R. SVP Controller Shares withheld for taxes −5,198 $842.66 $4.4M 20,942
2023-08-23 Fenimore Christopher R. SVP Controller Option exercise · Non-Qualified Stock Option (right to buy) −7,000 10,000

Page 49 of 49 · 971 trades